跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INTELLI-DESVENLAFAXINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INTELLI-DESVENLAFAXINE
Authorized
STANDARD
INTELLI-DESVENLAFAXINE
Intellipharmaceutics Corp
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
693c9c82bc19ba0a
Company
Intellipharmaceutics Corp
Type
Standard
Approval Details
Approval Id
693c9c82bc19ba0a
Drug Approval Canada Name
INTELLI-DESVENLAFAXINE
Product Name
INTELLI-DESVENLAFAXINE
Status
Approved
Status Date
2022-02-14
Din
02469855
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX23 DESVENLAFAXINE
Atc Name
n 06 ax 23
Aig Number
0152509002
Company Name
Intellipharmaceutics Corp
Company Address
30 Worcester Road, Toronto, Ontario, Canada, M9W 5X2
Company Detail Path
/organization/intellipharmaceutics-corp
Company Information
Pharmaceutical Company Name
Intellipharmaceutics Corp
Country Name
Canada
Province Name
Ontario
City Name
etobicoke,ontario,country_ca
Address
30 Worcester Rd
Active Ingredients
DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
693c9c82bc19ba0a
Type
Standard
Back to Health Canada Approvals